- Telehealth Visits
- Insurance plan information
Ginger Cupit, DO
Family Medicine • Women's Health- Telehealth Visits
- Insurance plan information
Ginger Cupit, DO
Family Medicine • Women's Health- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Sports Medicine, American Board of Family Medicine
- Family Medicine, American Board of Family Medicine
Fellowship
- Sports Medicine, UCSF Graduate Medical Education
Residency
- Family Medicine, Georgetown Univ/Providence Hospital FP Residency
Internship
- Family Medicine, Georgetown Univ/Providence Hospital FP Residency
Degree
- DO, Oregon Health Sciences University - Ashland
My expertise
Specialties
- Family Medicine
- Women's Health
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%223574%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223574%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 139 reviews
- January 28, 20265 out of 5 Stars
Dr Cupit is great. I feel like I am in good hands with her care. Shes very personable and hears me out.
- January 26, 20265 out of 5 Stars
Super woman!
- January 22, 20265 out of 5 Stars
Love Dr. Cupit. She is caring and understanding.
- January 22, 20265 out of 5 Stars
Exceptional care provided, thoughtful, professional, thorough and compassionate
- December 17, 20255 out of 5 Stars
Dr. Cupit is the best MD I've ever had!!!
- December 14, 20253.2 out of 5 Stars
End of meeting with Dr was rushed and provider was not clear on next steps. This was a first consultation, so a roadmap for treatment across the next few months / year would have been helpful.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.